Correction for Curtis et al., Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases

Key Points

• Fragmentation signatures in cancer patients show notable similarities to those found in vascular diseases and autoimmune diseases.
• In identifying these biomarkers, the study highlights potential shared pathways and mechanisms between these conditions.
• Observational analysis reveals that cancer patients exhibit fragmentation signatures that could indicate broader systemic health issues.
• These findings signify potential implications for understanding cancer's overlap with vascular and autoimmune diseases, urging further research.